Back to search
FDAFDA · Food and drugs·Recall number Z-2306-2026

MAC 5 A4 Resting ECG Analysis System 855001-001; MAC 5 A5 Resting ECG Analysis System 8855002-001. Electrocardiograph

Published June 10, 2026 · Recall initiated: April 21, 2026

Summary

FDA records medical device Class II recall Z-2306-2026, published June 10, 2026 and initiated April 21, 2026. Recalling firm: GE Medical Systems China Co., Ltd.; Status: Ongoing; Reported quantity: 16; Lot: Software version 3.00 855001-001, UDI-DI 00195278276070 8855002-001, UDI-DI 00195278276124. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Software in development inadvertently made available for customer use. Use of this software version can result in clinical information being associated with the incorrect patient. This could impact clinical decision-making.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
GE Medical Systems China Co., Ltd.
Distributor
Worldwide - US Nationwide distribution in the states of Florida and Georgia. The countries of India, Italy, Republic of Korea, and United Kingdom.
Lot
Software version 3.00 855001-001, UDI-DI 00195278276070 8855002-001, UDI-DI 00195278276124
Risk classification
Class II
Area (FDA)
device
Country
China

Related recalls

Questions about this recall

Was MAC 5 A4 Resting ECG Analysis System 855001-001; MAC 5 A5 Resting ECG Analysis System 8855002-001. Electrocardiograph recalled?

Yes. FDA published recall Z-2306-2026 on June 10, 2026. Reported hazard: Software in development inadvertently made available for customer use. Use of this software version can result in clinical information being associated with the incorrect patient. This could impact clinical decision-making.

What should I do if I have this product?

Voluntary: Firm initiated